Understanding scope of practice and accountability when prescribing This article introduces the core components of professionalism for prescribing pharmacists and shows how these concepts can be used to enhance decision making and promote safe and effective prescribing practice.…
Evaluation report of community pharmacy clinical services delayed until spring 2025, says NHS England Exclusive: NHS England said the delay is to avoid releasing an incomplete report, which could infer inaccurate suggestions relating to the pharmacy sector and damage patient confidence.…
Community pharmacy bodies call for funding support towards impending national insurance hike Organisations have written to the chancellor over concerns that the planned employer national insurance contribution increase will hinder their ability to offer clinical services and support.…
Pharmacy professionals will be vital to the MHRA’s regulatory work in 2025 The chief executive of the Medicines and Healthcare products Regulatory Agency reviews the successes of 2024 in medicine regulation and looks at where improvements can be made in the year ahead.…
Llewellyn Baker (1942–2024)On 19 December 2024, Llewellyn Baker MPharmS, aged 82 years, of North Ferriby, Yorkshire. Mr Baker registered with the Society in 1969.…
Pharmacists may take collective action by end of January over contract delay, warns NPA Pharmacies may begin to limit service provision in the wake of continued delays to community pharmacy contract negotiations, according to a statement released by the National Pharmacy Association.…
‘A wicked problem’: tackling variable access to urgent palliative care medicines Despite national incentives and locally commissioned services designed to improve availability of critical end-of-life drugs from community pharmacies, access to urgent palliative care medicines remains a challenge.…
Health inequalities included in updated cancer referral guidelines The Scottish government's ‘Cancer Strategy for Scotland 2023–2033’ highlights that there is “convincing evidence” that socioeconomic and health disparities are linked with increased diagnoses of more advanced cancers.…
Government to ‘maximise’ Pharmacy First use as part of plan to tackle NHS waiting lists Ear, nose and throat services will be one of five areas where targeted reforms will aim to move treatment from hospitals to the community.…
Optimising use of SGLT2 inhibitors in hospital patients How pharmacists can evaluate SGLT2 inhibitor use in hospitalised patients with a well-balanced approach so that patients can simultaneously benefit from SGLT2 inhibitors and the reduction of diabetic ketoacidosis risk.…
